Spry Health Lands $5.5M to Fund Commercialization of Clinical-Grade Wearable

Spry Health, a Palo Alto, CA-based provider of remote patient monitoring solutions has raised $5.5 million in Series A funding led by Grove Ventures with participation from the Stanford-StartX Fund.  The company plans to use the round to fuel the commercialization of its clinical-grade wearable Loop that delivers continuous vital sign monitoring. Loop enhances timely care to chronically ill patients, with individualized analytics to improve patient outcomes, reduce hospitalization and decrease spending by healthcare organizations.

Incubated at Stanford-affiliated accelerator StartX in 2013, founders Pierre-Jean “PJ” Cobut and Elad Ferber started Spry Health with a mission to help chronically ill patients receive proactive care and help them stay out of the hospital. Spry Health developed the clinical-grade wearable Loop to be a catalyst for both better care and lower costs.

The Loop wearable continuously and noninvasively collects vital signs to assess the patient’s baseline and monitor how their condition evolves. Loop’s analytics platform pinpoints subtle physiological changes and delivers relevant, actionable insights to healthcare organizations before new symptoms are noticeable to the patient. Healthcare organizations can then guide their most vulnerable members to the right care at the right time.  The combination of an easy-to-use wearable with individualized analytics increases peace of mind and compliance for patients, improves their outcomes, and prevents costly hospitalizations.